CCTC(SZ:300408)2022-04-28 16:00Financial Performance - The company's operating revenue for Q1 2022 was CNY 1,401,514,345.68, representing a 7.07% increase compared to CNY 1,308,965,700.85 in the same period last year[3]. - Net profit attributable to shareholders was CNY 497,535,135.99, a 1.59% increase from CNY 489,755,903.98 year-on-year[3]. - The weighted average return on net assets decreased to 3.03%, down from 4.43% in the same period last year, reflecting a decline in profitability[3]. - Net profit for the current period was ¥498,021,711.23, slightly up from ¥490,519,751.73 in the previous period, reflecting a growth of 1.03%[16]. - Basic earnings per share for the current period was ¥0.26, down from ¥0.27 in the previous period[17]. Cash Flow - The net cash flow from operating activities increased by 19.65% to CNY 472,823,284.78, up from CNY 395,160,613.56 in the previous year[3]. - Operating cash inflow totaled ¥1,960,238,777.56, an increase from ¥1,399,083,637.54 in the previous period[18]. - Cash outflow from operating activities was ¥1,487,415,492.78, compared to ¥1,003,923,023.98 in the previous period, indicating a rise of 48.06%[19]. - The net cash flow from investment activities was -¥1,509,682,990.82, worsening from -¥121,393,500.67 in the previous period[19]. - The ending balance of cash and cash equivalents was ¥4,503,269,119.76, down from ¥5,543,423,428.51 at the beginning of the period[41]. Assets and Liabilities - The total assets at the end of the reporting period were CNY 18,844,681,149.41, a 1.21% increase from CNY 18,620,049,198.40 at the end of the previous year[3]. - The total liabilities decreased to CNY 2.16 billion from CNY 2.43 billion, indicating a reduction of approximately 11.03%[13]. - The company's total equity attributable to shareholders increased by 3.02% to CNY 16,679,018,463.20 from CNY 16,190,296,603.57 at the end of the previous year[3]. - The company's non-current assets totaled CNY 6.05 billion, an increase from CNY 5.83 billion, representing a growth of approximately 3.67%[13]. - The company's goodwill decreased from ¥218,034,397.23 to ¥213,957,407.38, a reduction of approximately 1.8%[33]. Investment and Expenses - Research and development expenses rose significantly by 68.65% to CNY 120,885,512.66, compared to CNY 71,678,737.19 in the previous year, indicating increased investment in product competitiveness[6]. - The company reported a significant increase in investment income of 80.27%, amounting to CNY 42,654,175.33, compared to CNY 23,660,710.83 in the previous year[6]. - Total operating costs increased to ¥930,491,693.23, up 15.31% from ¥806,817,574.31 in the previous period[15]. - The company's other income for Q1 2022 was CNY 45,362,506.72, down from CNY 58,621,816.88 in the previous year, a decrease of 22.6%[37]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 33,882, indicating a stable shareholder base[7]. - The total number of restricted shares held by major shareholders is 165,679,610, with 110,880 shares released during the period[31]. - The total number of shares held by the largest shareholder, Chaozhou Sanjiang Investment Co., Ltd., is 645,357,856[30]. Market and Product Development - The company has not disclosed any new product or technology developments in the current report[31]. - There are no significant market expansion or merger and acquisition strategies mentioned in the current report[31].